Local Pharmacovigilance Matters: Where Global Strategy Meets On-the-Ground Reality
Local Pharmacovigilance Matters: Where Global Strategy Meets On-the-Ground Reality
Monday, 06 October 2025
Almudena del Castillo, Country Manager Spain & Head of Global Vigilance Division at QbD Group
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
Global PV success requires more than compliance. Discover how hybrid pharmacovigilance models help pharma companies meet local regulatory demands and build patient trust.
Play
Local Pharmacovigilance: Global Ambition Requires Local Insight | QbD Group
AI-generated audio
3:21
As pharma and biotech companies expand globally, one of the most underestimated challenges they face is adapting pharmacovigilance (PV) practices to the realities of each new market. Regulatory compliance might seem like a matter of following a rulebook—but in practice, it’s far more nuanced.
In this blog post, we explore why effective local PV is not just about ticking regulatory boxes. It’s about aligning with local expectations, bridging cultural interpretations of safety, and building trust from the ground up.
Understanding the local pharmacovigilance landscape
Even in regions that aim for regulatory harmonization—like the European Union (EU) or the Middle East and North Africa (MENA)—the interpretation and implementation of PV regulations can vary significantly from country to country.
In emerging markets, where frameworks are rapidly evolving, staying compliant requires agility, foresight, and deep local insight.
Pharma companies often encounter:
- fragmented or ambiguous national regulations open to interpretation
- a shortage of local experts with strong PV experience
- gaps between centralized global PV systems and the realities of local processes
- reactive communication between global headquarters and regional affiliates
Left unaddressed, these challenges can evolve from operational difficulties into serious compliance risks.
Webinar on demand
Scaling Pharmacovigilance in Europe
Learn practical, proven strategies for balancing global and local Pharmacovigilance and meeting strict European timelines efficiently. Watch this webinar on demand.
The rise of the hybrid PV model
To bridge this gap, many organizations are turning to a hybrid pharmacovigilance model—one that combines the strategic oversight of in-house PV teams with the agility and local knowledge of trusted external partners.
By outsourcing operational PV activities to reliable providers with regional presence, companies can:
- Empower local teams as strategic partners who contribute early insights into regulatory changes, cultural sensitivities, and risk perceptions
- Build scalable frameworks that allow for global consistency while supporting local customization
- Maintain continuous communication to improve audit readiness, regulatory relationships, and internal alignment
- Embed a patient-first mindset that transcends borders, languages, and reporting systems
Global consistency, local intelligence
Striking the right balance between global standardization and local nuance is no small feat. But when done well, it results in:
- stronger compliance,
- faster market access,
- and ultimately, safer outcomes for patients.
Effective pharmacovigilance goes beyond systems and SOPs. It’s about leadership, collaboration, and—above all—a commitment to listening: to regulators, to patients, to local teams, and to early signals in every market.
When global ambition meets local intelligence, companies move beyond compliance—they become trusted leaders in patient safety.
Need support managing local PV complexity?
At QbD Group, we help pharma and biotech companies scale their pharmacovigilance systems with a smart mix of global consistency and local adaptability.
Whether you're expanding into new markets or facing regional PV challenges, our experts and network of local partners can support your hybrid model—so you stay compliant, agile, and ahead of the curve.
Let’s build a safer global future, one market at a time.
Don’t hesitate to get in touch.
Need post-market vigilance support?
Our Global Safety Solutions supports your products post-market with vigilance, safety, and compliance.
Explore our solutions.
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Discover more expert content
Webinar
Scaling Pharmacovigilance in Europe: A Practical Guide for Pharma SMEs and Biotechs
This webinar on demand will provide clear, experience-based guidance on how to manage pharmacovigilance (PV) across Europe without overextending your resources. You’ll learn how to balance global consistency with country-specific requirements, meet strict European timelines with lean teams, and apply practical, proven strategies that strengthen both central oversight and local execution.
Webinar
Pharmacovigilance and Risk Management in Innovative Therapies: A Challenge in Drug Safety
Explore pharmacovigilance in cell, CAR T, and RNA therapies. Join our webinar to tackle tomorrow’s drug safety and risk management challenges.
.jpg)
Webinar
Unlocking Strategic Value in Drug Safety for Life Sciences Organizations
Explore how drug safety teams can transform into proactive benefit drivers with the right tools & resources in this webinar on demand.
Whitepaper
The One-Vigilance strategic roadmap to corporate excellence
This whitepaper introduces the concept of One Vigilance within the context of the current drug safety landscape. Download now.
Whitepaper
Ensuring compliance and quality in Pharmacovigilance
The whitepaper emphasizes the importance of a robust pharmacovigilance QMS and a well-maintained Pharmacovigilance System Master File (PSMF). Download now.
Case study
Optimizing pharmacovigilance for a biotechnology leader
Discover how QbD Group improved pharmacovigilance for a global leader in biotechnology, ensuring regulatory compliance and patient safety.
Case study
Revolutionizing pharmacovigilance: a success story of strategic partnership and seamless integration
Discover how QbD Group's expert support enhanced a pharmaceutical company's pharmacovigilance, leading to a favorable inspection outcome by the local Regulatory Authority (AEMPS).
.jpg)
Case study
Patient Support Program (PSP)
Learn about our patient support program (PSP) and how it helps manage customer support for a PV Spanish client. Resolve quality issues and ensure stability with QbD Pharma.
Twitter Widget Iframe